SI3595667T1 - Farmacevtski sestavki, ki obsegajo zaviralec jak - Google Patents

Farmacevtski sestavki, ki obsegajo zaviralec jak

Info

Publication number: SI3595667T1
Authority: SI; Slovenia
Prior art keywords: pharmaceutical compositions; jak inhibitor; jak; inhibitor; pharmaceutical
Prior art date: 2017-03-14

Application number

SI201831050T

Other languages

English (en)

Inventor

David Alonzo

Bei Li

Dimitrios Stefanidis

Original Assignee

Galapagos Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-03-14

Filing date

2018-03-12

Publication date

2024-03-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61768547&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3595667(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-03-12 Application filed by Galapagos Nv filed Critical Galapagos Nv

2024-03-29 Publication of SI3595667T1 publication Critical patent/SI3595667T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Inorganic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SI201831050T 2017-03-14 2018-03-12 Farmacevtski sestavki, ki obsegajo zaviralec jak SI3595667T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201762471171P	2017-03-14	2017-03-14
US201762536614P	2017-07-25	2017-07-25
PCT/US2018/022027 WO2018169875A1 (en)	2017-03-14	2018-03-12	Pharmaceutical compositions comprising a jak inhibitor
EP18713553.8A EP3595667B1 (en)	2017-03-14	2018-03-12	Pharmaceutical compositions comprising a jak inhibitor

Publications (1)

Publication Number	Publication Date
SI3595667T1 true SI3595667T1 (sl)	2024-03-29

Family

ID=61768547

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201831050T SI3595667T1 (sl)	2017-03-14	2018-03-12	Farmacevtski sestavki, ki obsegajo zaviralec jak

Country Status (23)

Country	Link
US (3)	US20180263997A1 (sl)
EP (2)	EP3595667B1 (sl)
JP (2)	JP6979080B2 (sl)
KR (2)	KR102303052B1 (sl)
CN (2)	CN116059211A (sl)
AU (2)	AU2018236156A1 (sl)
BR (1)	BR102018004952A2 (sl)
CA (1)	CA3055955C (sl)
DK (1)	DK3595667T3 (sl)
ES (1)	ES2969519T3 (sl)
FI (1)	FI3595667T3 (sl)
HR (1)	HRP20240112T1 (sl)
HU (1)	HUE065239T2 (sl)
JO (1)	JOP20180018A1 (sl)
LT (1)	LT3595667T (sl)
PL (1)	PL3595667T3 (sl)
PT (1)	PT3595667T (sl)
RS (1)	RS65118B1 (sl)
SI (1)	SI3595667T1 (sl)
SM (1)	SMT202400019T1 (sl)
TW (1)	TWI670270B (sl)
UY (1)	UY37632A (sl)
WO (1)	WO2018169875A1 (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201402071D0 (en)	2014-02-07	2014-03-26	Galapagos Nv	Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201808575D0 (en) *	2018-05-24	2018-07-11	Galapagos Nv	Methods for the treatment of psoriatic arthrits
US20220072002A1 (en) *	2018-12-24	2022-03-10	Chia Tai Tianqing Pharmaceuticalgroup Co., Ltd.	Treatment use of pyrrolopyrimidine compound, and solid pharmaceutical composition of pyrrolopyrimidine compound
WO2020177705A1 (zh) *	2019-03-05	2020-09-10	苏州科睿思制药有限公司	Filgotinib的马来酸盐晶型CSI及其制备方法和用途
WO2021044327A1 (en) *	2019-09-03	2021-03-11	Dr. Reddy's Laboratories Limited	Solid forms of filgotinib maleate and processes thereof
CN111672456A (zh) *	2020-06-18	2020-09-18	贵州大学	一种新型球-棒结构的介孔Janus纳米粒子及其制备方法
TW202508595A (zh)	2023-05-04	2025-03-01	美商銳新醫藥公司	用於ｒａｓ相關疾病或病症之組合療法
WO2025034702A1 (en)	2023-08-07	2025-02-13	Revolution Medicines, Inc.	Rmc-6291 for use in the treatment of ras protein-related disease or disorder
US20250154171A1 (en)	2023-10-12	2025-05-15	Revolution Medicines, Inc.	Ras inhibitors
WO2025171296A1 (en)	2024-02-09	2025-08-14	Revolution Medicines, Inc.	Ras inhibitors
WO2025240847A1 (en)	2024-05-17	2025-11-20	Revolution Medicines, Inc.	Ras inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003032954A1 (en)	2001-10-17	2003-04-24	Dr. Reddy's Laboratories Ltd.	Stabilized pharmaceutical formulations containing amlodipine maleate
TWI462920B (zh)	2009-06-26	2014-12-01	葛萊伯格有限公司	用於治療退化性及發炎疾病之新穎化合物
GB201402070D0 (en)	2014-02-07	2014-03-26	Galapagos Nv	Pharmaceutical compositions for the treatment of inflammatory disorders
GB201402071D0 (en)	2014-02-07	2014-03-26	Galapagos Nv	Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
WO2017012770A1 (en)	2015-07-23	2017-01-26	Ratiopharm Gmbh	Acid addition salts of filgotinib

2017
- 2017-03-14 JO JOP/2018/0018A patent/JOP20180018A1/ar unknown
2018
- 2018-03-12 JP JP2019550213A patent/JP6979080B2/ja active Active
- 2018-03-12 HR HRP20240112TT patent/HRP20240112T1/hr unknown
- 2018-03-12 AU AU2018236156A patent/AU2018236156A1/en not_active Abandoned
- 2018-03-12 PT PT187135538T patent/PT3595667T/pt unknown
- 2018-03-12 EP EP18713553.8A patent/EP3595667B1/en active Active
- 2018-03-12 KR KR1020197029508A patent/KR102303052B1/ko active Active
- 2018-03-12 LT LTEPPCT/US2018/022027T patent/LT3595667T/lt unknown
- 2018-03-12 WO PCT/US2018/022027 patent/WO2018169875A1/en not_active Ceased
- 2018-03-12 SM SM20240019T patent/SMT202400019T1/it unknown
- 2018-03-12 CN CN202310082905.7A patent/CN116059211A/zh active Pending
- 2018-03-12 PL PL18713553.8T patent/PL3595667T3/pl unknown
- 2018-03-12 RS RS20240079A patent/RS65118B1/sr unknown
- 2018-03-12 CN CN201880018328.2A patent/CN110418644A/zh active Pending
- 2018-03-12 HU HUE18713553A patent/HUE065239T2/hu unknown
- 2018-03-12 FI FIEP18713553.8T patent/FI3595667T3/fi active
- 2018-03-12 US US15/918,765 patent/US20180263997A1/en not_active Abandoned
- 2018-03-12 DK DK18713553.8T patent/DK3595667T3/da active
- 2018-03-12 ES ES18713553T patent/ES2969519T3/es active Active
- 2018-03-12 EP EP23208646.2A patent/EP4368173A3/en active Pending
- 2018-03-12 SI SI201831050T patent/SI3595667T1/sl unknown
- 2018-03-12 KR KR1020217029180A patent/KR102425226B1/ko active Active
- 2018-03-12 CA CA3055955A patent/CA3055955C/en active Active
- 2018-03-13 BR BR102018004952A patent/BR102018004952A2/pt not_active Application Discontinuation
- 2018-03-13 TW TW107108404A patent/TWI670270B/zh active
- 2018-03-14 UY UY0001037632A patent/UY37632A/es not_active Application Discontinuation
2021
- 2021-01-15 AU AU2021200229A patent/AU2021200229B2/en active Active
- 2021-02-26 US US17/186,446 patent/US11975008B2/en active Active
- 2021-09-16 JP JP2021150706A patent/JP2022003053A/ja active Pending
2024
- 2024-04-05 US US18/628,560 patent/US20240277725A1/en active Pending

Also Published As

Publication number	Publication date
AU2018236156A1 (en)	2019-09-19
HUE065239T2 (hu)	2024-05-28
LT3595667T (lt)	2024-01-25
TW201837038A (zh)	2018-10-16
CN116059211A (zh)	2023-05-05
TWI670270B (zh)	2019-09-01
HRP20240112T1 (hr)	2024-04-12
CN110418644A (zh)	2019-11-05
JP6979080B2 (ja)	2021-12-08
EP4368173A2 (en)	2024-05-15
KR102425226B1 (ko)	2022-07-27
SMT202400019T1 (it)	2024-03-13
DK3595667T3 (da)	2024-01-15
EP4368173A3 (en)	2024-06-12
CA3055955C (en)	2023-03-28
US11975008B2 (en)	2024-05-07
FI3595667T3 (fi)	2024-01-12
BR102018004952A2 (pt)	2018-10-30
PL3595667T3 (pl)	2024-03-18
KR20190122827A (ko)	2019-10-30
EP3595667B1 (en)	2023-12-20
PT3595667T (pt)	2024-02-01
ES2969519T3 (es)	2024-05-21
CA3055955A1 (en)	2018-09-20
US20180263997A1 (en)	2018-09-20
WO2018169875A1 (en)	2018-09-20
JP2022003053A (ja)	2022-01-11
JP2020510057A (ja)	2020-04-02
KR102303052B1 (ko)	2021-09-23
JOP20180018A1 (ar)	2019-01-30
AU2021200229A1 (en)	2021-03-18
AU2021200229B2 (en)	2022-07-07
US20240277725A1 (en)	2024-08-22
KR20210117345A (ko)	2021-09-28
EP3595667A1 (en)	2020-01-22
US20210353634A1 (en)	2021-11-18
UY37632A (es)	2018-04-30
RS65118B1 (sr)	2024-02-29

Publication	Publication Date	Title
LT3595667T (lt)	2024-01-25	Farmacinė kompozicija, apimanti jak inhibitorių
IL271657A (en)	2020-02-27	medical preparation
IL269061A (en)	2019-11-28	A pharmaceutical preparation containing Selexifag
PL3248980T3 (pl)	2024-03-04	Inhibitor jak
GB201608323D0 (en)	2016-06-29	Pharmaceutical compositions
IL271759B1 (en)	2023-09-01	Pharmaceutical preparations that include anthraxtinib
ES3041841T3 (en)	2025-11-14	Formulations/compositions comprising a btk inhibitor
GB201705303D0 (en)	2017-05-17	Pharmaceutical compositions
SG11202001179YA (en)	2020-03-30	Pharmaceutical compositions
GB201804548D0 (en)	2018-05-02	Pharmaceutical compositions
GB201705305D0 (en)	2017-05-17	Pharmaceutical compositions
GB201705304D0 (en)	2017-05-17	Pharmaceutical compositions
GB201808571D0 (en)	2018-07-11	Pharmaceutical compositions
GB201705306D0 (en)	2017-05-17	Pharmaceutical compositions
GB202007031D0 (en)	2020-06-24	Aerosol compositions
GB201808567D0 (en)	2018-07-11	Pharmaceutical compositions
ZA202000014B (en)	2021-10-27	Pharmaceutical compositions
IL263999A (en)	2019-01-31	Pharmaceutical compositions
IL272044A (en)	2020-03-31	Pharmacy preparations
HK40111325A (en)	2025-01-03	Pharmaceutical compositions comprising a jak inhibitor
ZA201705782B (en)	2018-12-19	Pharmaceutical compositions
IL272428A (en)	2020-03-31	pharmaceutical preparations
ZA201801904B (en)	2019-01-30	A pharmaceutical composition
GB201715881D0 (en)	2017-11-15	New pharmaceutical compositions
GB201810265D0 (en)	2018-08-08	New pharmaceutical compositions